WHO Pharmaceuticals Newsletter 1999, No. 01&02
(1999; 16 pages)
Table of Contents
Close this folderRegulatory actions
View the documentAlbumin (human): batches withdrawn: increase in aluminium level: Germany
View the documentAlfalfa products: caution label: Malaysia
View the documentAmineptine: marketing authorization suspended: drug abuse and dependence: France
View the documentAstemizole: OTC formulations withdrawn: UK
View the documentCisapride: restricted indications: Ireland
View the documentDronabinol: proposed reclassificaion from Schedule II to Schedule III of the US Controlled Substances Act: USA
View the documentEntacapone: revised product information: caution concerning use: EMEA
View the documentFurazolidone: withdrawn: Yemen
View the documentGinkgo biloba parenteral infusion formulation: suspension further extended: Germany
View the documentIsotretinoin: revised prescribing information: depression: Ireland
View the documentKaolin and pectin suspension: withdrawn: Yemen
View the documentLevocarnitine: revised data sheet: seizures: USA
View the documentLoratadine/pseudoephedrine sulfate: reformulated: UK
View the documentMetamizole sodium: withdrawn due to agranulocytosis: Yemen
View the documentMethadone mixture: child-resistant packaging recommended: Germany
View the documentMethylrosanilinium chloride (Gentian violet): withdrawn: Malaysia
View the documentMontelukast: revised data sheet: eosinophilia: UK
Open this folder and view contentsDrug surveillance
Open this folder and view contentsNew developments
Open this folder and view contentsGeneral information
Open this folder and view contentsMedication errors
Open this folder and view contentsVeterinary medicine
 

Alfalfa products: caution label: Malaysia

Malaysia. After reviewing the adverse reactions associated with the ingestion of products containing alfalfa (Medicago sativa), the Drug Control Authority has issued an additional requirement for all such products in which alfalfa is the major component. These products should carry the following statement:

“This products contains alfalfa (Medicago sativa). Individuals with a predisposition to systemic lupus erythematosus should consult their physicians before consuming this product.”

The amino acid, canavanine, found in the alfalfa seeds, is thought to be the factor contributing to the exacerbation of systemic lupus erythematosus in consumers with a predisposition to this condition.

Reference: Berita Ubat-Ubatan (Drug Information) Vol. 12, No. 2, August 1998.

to previous section to next section
 

Last updated: May 3, 2013